NanoViricides (NNVC) News Today $1.50 +0.05 (+3.45%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.54 +0.03 (+2.33%) As of 02/21/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Small cap headlines: EnWave, NanoViricides, GoviEx, TNR GoldFebruary 21 at 3:31 PM | proactiveinvestors.comNanoViricides reports Q2 EPS (14c) vs. (18c) last yearFebruary 19 at 1:06 PM | markets.businessinsider.comNanoViricides targets key milestones in 2025 with NV-387 advancing to Phase II trialsFebruary 19 at 9:40 AM | proactiveinvestors.comNanoViricides announces readiness to combat bird flu with antiviral drug NV-387February 11, 2025 | proactiveinvestors.comNanoViricides seeks to eliminate treatment delays with its broad spectrum antiviral NV-387February 4, 2025 | proactiveinvestors.comNanoViricides warns of bird flu pandemic as outbreak spreads in MassachusettsJanuary 31, 2025 | proactiveinvestors.comNanoViricides taps clinical research organization for Phase II trial of NV-387January 27, 2025 | proactiveinvestors.comNanoViricides CEO discusses NV-387's broad spectrum promise - ICYMIJanuary 11, 2025 | proactiveinvestors.comNanoViricides: Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum AntiviralsJanuary 8, 2025 | finanznachrichten.deNanoViricides highlights urgent need for broad-spectrum antiviral solutions amid viral threatsJanuary 8, 2025 | proactiveinvestors.comNanoViricides sees NV-387 as a key defense against bird flu pandemicDecember 23, 2024 | proactiveinvestors.comNanoViricides CEO highlights urgency of H5N1 preparedness as cases rise in North AmericaDecember 6, 2024 | proactiveinvestors.comNanoViricides pushes NV-387 to Phase II trialsNovember 15, 2024 | proactiveinvestors.comNanoViricides Inc. (NNVC): Best Nanotech Penny Stock to BuyOctober 14, 2024 | msn.comInvestorNewsBreaks – NanoViricides Inc. (NYSE American: NNVC) to Discuss Its ‘Trojan Horse’ Platform Technology at Upcoming Global AMR SummitOctober 8, 2024 | msn.comNanoViricides prepares for Phase II trials for antiviral NV-387September 30, 2024 | proactiveinvestors.comNanoviricides (AMEX:NNVC) Stock Quotes, Forecast and News SummarySeptember 27, 2024 | benzinga.comNanoViricides expands antiviral drug pipeline with TheraCour Pharma agreementSeptember 26, 2024 | proactiveinvestors.comNanoViricides CEO talks lead drug asset's potential as MPOX therapy - ICYMISeptember 14, 2024 | proactiveinvestors.comNanoViricides exploring emergency protocol to evaluate NV-387 for MPOXAugust 26, 2024 | proactiveinvestors.comNanoViricides prepares for Phase II trial of broad-spectrum antiviral NV-387August 19, 2024 | proactiveinvestors.comNanoViricides reports major progress in advancing broad-spectrum antiviral drug NV-387August 8, 2024 | proactiveinvestors.comFrontier Biotechnologies Inc. (688221.SS)August 8, 2024 | finance.yahoo.comNanoViricides' lead asset for broad spectrum efficacy wins praise in industry reportsAugust 1, 2024 | proactiveinvestors.comNNVC: NanoViricides Broad Spectrum Technology Represents Potential Paradigm Shift in Viral TherapyJuly 31, 2024 | msn.comNanoViricides spotlights lead drug candidate's potential as COVID therapyJuly 24, 2024 | proactiveinvestors.comNanoViricides discusses lead program and next stepsJuly 11, 2024 | proactiveinvestors.comNanoViricides hails broad potential of lead antiviral drug as it prepares to begin first Phase II trialJuly 1, 2024 | proactiveinvestors.comNanoViricides hails the potential of NV-387 in combatting bird flu virus H5N1June 24, 2024 | proactiveinvestors.comNanoViricides says antiviral drug candidate shows promise in protecting lungs against Influenza AJune 20, 2024 | proactiveinvestors.comNanoViricides antiviral candidate 'may be first effective oral nanomedicine'June 11, 2024 | proactiveinvestors.comNanoViricides says lead asset exhibits desirable blood concentration profile for infrequent dosingJune 4, 2024 | proactiveinvestors.comA First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and MoreMay 29, 2024 | finance.yahoo.comNanoViricides CEO says lead asset NV-387 could be ‘holy grail' of antiviral medicinesMay 29, 2024 | proactiveinvestors.comNanoViricides taps Aagami to seek out licensing and partnership opportunitiesMay 23, 2024 | proactiveinvestors.comNanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.May 23, 2024 | finance.yahoo.comNanoViricides could generate ‘antiviral superdrug' for multiple diseases, analysts believeMay 21, 2024 | proactiveinvestors.comNanoViricides, Inc.: Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential CureMay 20, 2024 | finanznachrichten.deNanoViricides reports strong antiviral activity of NV-387 against RSVMay 20, 2024 | proactiveinvestors.comNanoViricides, Inc. (NNVC) Stock Price, News, Quote & History - Yahoo FinanceMay 19, 2024 | finance.yahoo.comNanoViricides unveils new data showing lead drug asset's strong activity against RSVMay 14, 2024 | proactiveinvestors.comA Novel Broad-Spectrum Antiviral with Activity Against RSVMay 14, 2024 | finance.yahoo.comNanoViricides CEO discusses NV-387's broad-spectrum antiviral potentialMay 13, 2024 | proactiveinvestors.comNanoViricides to showcase lead drug asset's progress at EF Hutton Annual Global ConferenceMay 10, 2024 | proactiveinvestors.comNanoViricides, Inc.: NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York CityMay 10, 2024 | finanznachrichten.deNanoViricides says lead asset shows antiviral activity against Smallpox and MpoxMay 8, 2024 | proactiveinvestors.comNanoViricides, Inc.: A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/MpoxMay 8, 2024 | finanznachrichten.deNanoViricides, Inc. (NNVC)May 8, 2024 | finance.yahoo.comNanoViricides drug asset shows ‘superior antiviral effects’ against Influenza AMay 6, 2024 | ca.investing.comNanoViricides, Outset Medical, EyePoint Pharmaceuticals among healthcare moversMay 6, 2024 | msn.com Get NanoViricides News Delivered to You Automatically Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter. Email Address NNVC Media Mentions By Week NNVC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NNVC News Sentiment▼0.250.60▲Average Medical News Sentiment NNVC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NNVC Articles This Week▼31▲NNVC Articles Average Week Get NanoViricides News Delivered to You Automatically Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mural Oncology News Tenaya Therapeutics News Applied Therapeutics News Genenta Science News Forte Biosciences News FitLife Brands News Aerovate Therapeutics News ZIVO Bioscience News Ikena Oncology News Reviva Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NNVC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoViricides With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
